InMed Pharmaceuticals files prospectus supplement for at-the-market share offering.
Share this article
Corporate
Score 25
Bearish
InMed Pharmaceuticals files prospectus supplement for at-the-market share offering
Apr 03, 2026 23:46 UTC
INM, ^GSPC
Short term
Related Articles
Score 25
Searby Sean, Amalgamated Financial EVP, sells $195k in AMAL stock
Apr 04, 00:37
Score 25
S&P 500 Index Offers Stability for Investors Amid Market Volatility
Apr 04, 00:36
Score 25
Rambus CEO Seraphin Luc sells shares worth $470k
Apr 04, 00:22
Score 25
Bearish
Apogee Therapeutics (APGE) CMO sells shares worth $466,619
Apr 04, 00:04
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.